23 Jun 2023Open access7cites
Integration of Hybridization Strategies in Pyridine–Urea Scaffolds for Novel Anticancer Agents: Design, Synthesis, and Mechanistic InsightsPublisher siteMolecules, Synthesis and biological activity
Active, last published 2026
In computational drug discovery methods
Hossam
Nada
Scholar“Research focused on Computational Drug Discovery Methods and adjacent fields.”
Claim Your Profile14
H-index
734
Citations
Hossam has not officially claimed their profile. If you are Hossam, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
ossam Nada is a researcher working on Computational Drug Discovery Methods. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Hossam's work has been cited 734 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Computational Drug Discovery Methods×8Synthesis and biological activity×7Monoclonal and Polyclonal Antibodies Research×6Cholinesterase and Neurodegenerative Diseases×6Cancer Immunotherapy and Biomarkers×5
04 · Where I am
Affiliations
Affiliation on published researchDongguk University, EgyptDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
5 works12 Jan 20238cites
Discovery and optimization of natural-based nanomolar c-Kit inhibitors via in silico and in vitro studiesPublisher siteJournal of Biomolecular Structure and Dynamics, Multiple Myeloma Research and Treatments
7 Oct 2022Open access45cites
Identification of 1H-purine-2,6-dione derivative as a potential SARS-CoV-2 main protease inhibitor: molecular docking, dynamic simulations, and energy calculationsPublisher sitePeerJ, Computational Drug Discovery Methods
17 Aug 2022Open access7cites
Novel cudraisoflavone J derivatives as potent neuroprotective agents for the treatment of Parkinson's disease via the activation of Nrf2/HO-1 signalingPublisher siteEuropean Journal of Medicinal Chemistry, Genomics, phytochemicals, and oxidative stress
25 Feb 2022Open access20cites
Identification of Novel and Potent Indole-Based Benzenesulfonamides as Selective Human Carbonic Anhydrase II Inhibitors: Design, Synthesis, In Vitro, and In Silico StudiesPublisher siteInternational Journal of Molecular Sciences, Enzyme function and inhibition
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Hossam?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you